Cacti Asset Management LLC Embecta Corp. Transaction History

Cacti Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 03, 2024	SELL	$12.35 - $19.33 $667,517 - $1.04 Million	-54,050 Reduced 94.25%	3,297 $43,000
Q4 2023 Jan 02, 2024	SELL	$12.87 - $19.09 $48,146 - $71,415	-3,741 Reduced 6.12%	57,347 $1.09 Million
Q2 2023 Jul 03, 2023	SELL	$21.6 - $30.69 $102,016 - $144,948	-4,723 Reduced 7.18%	61,088 $1.32 Million
Q1 2023 Apr 03, 2023	SELL	$23.07 - $32.77 $346 - $491	-15 Reduced 0.02%	65,811 $1.85 Million
Q4 2022 Jan 03, 2023	SELL	$25.29 - $35.48 $27,819 - $39,028	-1,100 Reduced 1.64%	65,826 $1.67 Million
Q3 2022 Oct 03, 2022	SELL	$24.0 - $33.42 $960 - $1,336	-40 Reduced 0.06%	66,926 $1.93 Million
Q2 2022 Jul 01, 2022	BUY	$24.78 - $33.36 $1.66 Million - $2.23 Million	66,966 New	66,966 $1.7 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Cacti Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cacti Asset Management LLC with notifications on news.